Faeth Therapeutics, Inc. (FTH)
12.68
-9.37
(-42.49%)
USD |
NASDAQ |
Nov 09, 16:00
12.39
-0.29
(-2.29%)
After-Hours: 04:30
Faeth Therapeutics Shareholders Equity (Quarterly) : 167.86M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 167.86M |
| June 30, 2026 | 179.72M |
| March 31, 2026 | 191.19M |
| December 31, 2025 | 18.59M |
| September 30, 2025 | 23.01M |
| June 30, 2025 | 27.31M |
| March 31, 2025 | 31.99M |
| December 31, 2024 | 38.39M |
| September 30, 2024 | 45.78M |
| June 30, 2024 | 52.19M |
| March 31, 2024 | 58.47M |
| December 31, 2023 | 64.90M |
| September 30, 2023 | 71.00M |
| June 30, 2023 | 79.20M |
| Date | Value |
|---|---|
| March 31, 2023 | 94.85M |
| December 31, 2022 | 103.41M |
| September 30, 2022 | 113.99M |
| June 30, 2022 | 125.92M |
| March 31, 2022 | 135.31M |
| December 31, 2021 | 146.51M |
| September 30, 2021 | 155.21M |
| June 30, 2021 | 163.12M |
| March 31, 2021 | 171.25M |
| December 31, 2020 | 15.89M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -21.12M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cypherpunk Technologies, Inc. | 139.32M |
| Zymeworks, Inc. | 80.37M |
| Rhythm Pharmaceuticals, Inc. | 201.54M |
| Cue Biopharma, Inc. | 2.31M |
| Yarrow Bioscience, Inc. | 22.06M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 178.95M |
| Total Liabilities (Quarterly) | 11.08M |
| Debt to Equity Ratio | 0.0009 |
| Current Ratio | 16.12 |
| Net Debt Paydown Yield | 0.06% |